Abstract
A patient with advanced unresectable fibrolamellar hepatocellular carcinoma is reported, who was treated with cisplatinum, epirubicin and 5-fluorouracil combination chemotherapy. Tumour regression was achieved, enabling major debulking surgery to be performed. The patient remains in clinical remission 11 months after completing therapy.
MeSH terms
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Biopsy
-
Carcinoma, Hepatocellular / diagnosis
-
Carcinoma, Hepatocellular / drug therapy*
-
Carcinoma, Hepatocellular / surgery
-
Cisplatin / administration & dosage
-
Combined Modality Therapy
-
Epirubicin / administration & dosage
-
Fluorouracil / administration & dosage
-
Humans
-
Leucovorin / administration & dosage
-
Liver / pathology
-
Liver Neoplasms / diagnosis
-
Liver Neoplasms / drug therapy*
-
Liver Neoplasms / surgery
-
Male
-
Tomography, X-Ray Computed
-
Treatment Outcome
Substances
-
Epirubicin
-
Cisplatin
-
Leucovorin
-
Fluorouracil